UK in talks with Palantir over COVID-19 test-and-trace program - FT
Reuters
Published Nov 03, 2020 18:35
Updated Nov 03, 2020 20:00
(Reuters) - The British government is in talks with U.S. data analytics company Palantir Technologies Inc in an attempt to strengthen its test-and-trace program for COVID-19, the Financial Times reported on Tuesday.
Officials have been in talks with the tech company about using its Foundry software to manage sensitive contact tracing data, the FT reported https://on.ft.com/3oNU121, citing people familiar with the matter.
UK Prime Minister Boris Johnson promised a "world-beating" national test-and-trace system earlier this year, whereby people with COVID-19 symptoms get tested and the contacts of positive cases are asked to self-isolate.
But the scheme has disappointed and the government's scientific advisory body said last month its impact on virus transmission was marginal.
Under the contract being discussed, the new modeling will potentially allow to track the spread of the disease through particular sectors or parts of the country, according to the FT report.
Palantir and Britain's Health Department did not immediately respond to Reuters' requests for comment.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.